43/120
1.8 / 5 stars
All 120 Win/Lose results shown below
TWST Roast Me summary
Twist Bioscience Corp (TWST). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinTWST / S&P 116.50% / 15.20% |
WinTWST / S&P 19.19% / 15.00% |
LoseTWST / S&P TWST unavailable / 50.40% |
| 2026-Q12/3 |
WinTWST / S&P 49.81% / -4.33% |
WinTWST / S&P 17.77% / 11.30% |
LoseTWST / S&P TWST unavailable / 27.70% |
| 2025-Q42/3 |
WinTWST / S&P 12.72% / 2.65% |
WinTWST / S&P 18.59% / 9.00% |
LoseTWST / S&P TWST unavailable / 13.40% |
| 2025-Q31/3 |
LoseTWST / S&P -23.51% / 8.12% |
WinTWST / S&P 20.32% / 4.61% |
LoseTWST / S&P TWST unavailable / 13.45% |
| 2025-Q21/3 |
LoseTWST / S&P -6.29% / 10.94% |
WinTWST / S&P 22.72% / 4.83% |
LoseTWST / S&P TWST unavailable / 10.63% |
| 2025-Q11/3 |
LoseTWST / S&P -15.52% / -4.27% |
WinTWST / S&P 25.30% / 4.98% |
LoseTWST / S&P TWST unavailable / 10.57% |
| 2024-Q42/3 |
WinTWST / S&P 2.86% / 2.41% |
WinTWST / S&P 25.85% / 5.25% |
LoseTWST / S&P TWST unavailable / 6.15% |
| 2024-Q31/3 |
LoseTWST / S&P -8.32% / 5.89% |
WinTWST / S&P 27.69% / 5.89% |
LoseTWST / S&P TWST unavailable / 6.11% |
| 2024-Q22/3 |
WinTWST / S&P 43.63% / 4.28% |
WinTWST / S&P 25.37% / 5.38% |
LoseTWST / S&P TWST unavailable / 5.12% |
| 2024-Q11/3 |
LoseTWST / S&P -6.92% / 10.56% |
WinTWST / S&P 21.79% / 5.71% |
LoseTWST / S&P TWST unavailable / 5.59% |
| 2023-Q42/3 |
WinTWST / S&P 81.93% / 11.69% |
WinTWST / S&P 21.58% / 6.81% |
LoseTWST / S&P TWST unavailable / 7.78% |
| 2023-Q32/3 |
WinTWST / S&P -0.98% / -3.27% |
WinTWST / S&P 20.41% / 7.52% |
LoseTWST / S&P TWST unavailable / -5.03% |
| 2023-Q22/3 |
WinTWST / S&P 35.68% / 8.74% |
WinTWST / S&P 27.83% / 9.50% |
LoseTWST / S&P TWST unavailable / -8.57% |
| 2023-Q11/3 |
LoseTWST / S&P -36.67% / 7.50% |
WinTWST / S&P 39.68% / 10.77% |
LoseTWST / S&P TWST unavailable / -15.69% |
| 2022-Q41/3 |
LoseTWST / S&P -32.43% / 7.56% |
WinTWST / S&P 47.61% / 11.88% |
LoseTWST / S&P TWST unavailable / -17.99% |
| 2022-Q32/3 |
WinTWST / S&P 0.80% / -4.88% |
WinTWST / S&P 53.83% / 13.47% |
LoseTWST / S&P TWST unavailable / -1.41% |
| 2022-Q21/3 |
LoseTWST / S&P -29.20% / -16.10% |
WinTWST / S&P 45.26% / 13.71% |
LoseTWST / S&P TWST unavailable / 11.04% |
| 2022-Q11/3 |
LoseTWST / S&P -36.19% / -4.60% |
WinTWST / S&P 44.34% / 15.97% |
LoseTWST / S&P TWST unavailable / 42.23% |
| 2021-Q41/3 |
LoseTWST / S&P -27.65% / 11.03% |
WinTWST / S&P 44.60% / 15.00% |
LoseTWST / S&P TWST unavailable / 96.40% |
| 2021-Q31/3 |
LoseTWST / S&P -19.72% / 0.58% |
WinTWST / S&P 46.87% / 10.77% |
LoseTWST / S&P TWST unavailable / 69.42% |
| 2021-Q21/3 |
LoseTWST / S&P 7.58% / 8.55% |
WinTWST / S&P 72.76% / 6.58% |
LoseTWST / S&P TWST unavailable / 51.81% |
| 2021-Q11/3 |
LoseTWST / S&P -12.34% / 6.17% |
WinTWST / S&P 71.74% / -1.06% |
LoseTWST / S&P TWST unavailable / 7.39% |
| 2020-Q42/3 |
WinTWST / S&P 85.98% / 12.15% |
WinTWST / S&P 68.33% / -3.72% |
LoseTWST / S&P TWST unavailable / -33.42% |
| 2020-Q32/3 |
WinTWST / S&P 67.70% / 8.93% |
WinTWST / S&P 65.67% / -2.04% |
LoseTWST / S&P TWST unavailable / -27.10% |
| 2020-Q22/3 |
WinTWST / S&P 48.14% / 20.54% |
WinTWST / S&P 55.99% / -0.46% |
LoseTWST / S&P TWST unavailable / -27.11% |
| 2020-Q12/3 |
WinTWST / S&P 45.62% / -19.60% |
WinTWST / S&P 64.51% / 3.47% |
LoseTWST / S&P TWST unavailable / -14.75% |
| 2019-Q41/3 |
LoseTWST / S&P -12.06% / 9.07% |
WinTWST / S&P 84.19% / 5.36% |
LoseTWST / S&P TWST unavailable / 2.99% |
| 2019-Q31/3 |
LoseTWST / S&P -17.68% / 1.70% |
WinTWST / S&P 113.89% / 5.02% |
LoseTWST / S&P TWST unavailable / 0.21% |
| 2019-Q21/3 |
WinTWST / S&P 25.15% / 4.30% |
LoseTWST / S&P TWST unavailable / 6.64% |
LoseTWST / S&P TWST unavailable / 8.65% |
| 2019-Q10/3 |
LoseTWST / S&P 0.39% / 13.65% |
LoseTWST / S&P TWST unavailable / 8.12% |
LoseTWST / S&P TWST unavailable / 14.29% |
| 2018-Q40/3 |
LoseTWST / S&P TWST unavailable / -13.52% |
LoseTWST / S&P TWST unavailable / 9.05% |
LoseTWST / S&P TWST unavailable / 18.23% |
| 2018-Q31/3 |
LoseTWST / S&P TWST unavailable / 7.71% |
WinTWST / S&P 136.16% / 10.21% |
LoseTWST / S&P TWST unavailable / 19.06% |
| 2018-Q20/3 |
LoseTWST / S&P TWST unavailable / 3.43% |
LoseTWST / S&P TWST unavailable / 9.03% |
LoseTWST / S&P TWST unavailable / 14.46% |
| 2018-Q10/3 |
LoseTWST / S&P TWST unavailable / -0.76% |
LoseTWST / S&P TWST unavailable / 7.68% |
LoseTWST / S&P TWST unavailable / 12.46% |
| 2017-Q40/3 |
LoseTWST / S&P TWST unavailable / 6.64% |
LoseTWST / S&P TWST unavailable / 7.03% |
LoseTWST / S&P TWST unavailable / 13.82% |
| 2017-Q30/3 |
LoseTWST / S&P TWST unavailable / 4.48% |
LoseTWST / S&P TWST unavailable / 5.68% |
LoseTWST / S&P TWST unavailable / 17.57% |
| 2017-Q20/3 |
LoseTWST / S&P TWST unavailable / 3.09% |
LoseTWST / S&P TWST unavailable / 4.83% |
LoseTWST / S&P TWST unavailable / 17.74% |
| 2017-Q10/3 |
LoseTWST / S&P TWST unavailable / 6.07% |
LoseTWST / S&P TWST unavailable / 3.67% |
LoseTWST / S&P TWST unavailable / 13.32% |
| 2016-Q40/3 |
LoseTWST / S&P TWST unavailable / 3.82% |
LoseTWST / S&P TWST unavailable / 2.09% |
LoseTWST / S&P TWST unavailable / 7.05% |
| 2016-Q30/3 |
LoseTWST / S&P TWST unavailable / 3.85% |
LoseTWST / S&P TWST unavailable / 0.20% |
LoseTWST / S&P TWST unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | TWST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 424.16% | 20.78% |
| Annualized return | 424.16% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | TWST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 20.78% | 83.14% |
| Annualized return | 3.85% | 12.86% |
10Y · 2018-10-31 to 2026-08-28
| Metric | TWST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 909.75% | 319.30% |
| Annualized return | 26.01% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |